Tirzepatide
Dual GIP and GLP-1 receptor agonist, 39 amino acids. For laboratory and research use only.
Specifications
| Size | 10mg, 20mg, 30mg, 40mg |
Description
Research Overview
Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide engineered as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Activating two incretin receptors rather than one is what distinguishes it structurally from single-receptor compounds such as semaglutide, and that dual-receptor design is the reason it has generated research interest in metabolic studies.
Specifications
- Form: Lyophilized powder
- Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
Certificate of Analysis
Independent third-party testing by Freedom Diagnostics. See the test results page for the reports we publish and what they can and cannot show.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.
